Gene Variant Databases

Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls, qualify candidate drug targets, and accelerate early discovery

March 13, 2024
The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity, the pace of development has never been faster. Biopharmaceutical companies can’t afford to waste time and resources pursuing ineffective or unsafe ideas.

In this talk, our experts discuss how biopharmaceutical companies can leverage key genomic, biomedical, and clinical trial databases to improve and accelerate cancer drug discovery while avoiding potential pitfalls. Through a series of use cases, attendees will learn about expert-curated knowledge from the Wellcome Sanger Institute and QIAGEN, and how to use these resources to better predict cancer-driving effects of mutations, identify available drugs that target specific variants, and accelerate indication expansion and repurposing of existing cancer therapies.

Learning objectives:

Examine use-cases of how to leverage expert-curated databases across multiple phases of cancer drug development.
Discover key applications of these databases, including determining the function, frequency, and actionability of specific mutations.
Discuss potential pitfalls and clinical consequences, and how to avoid them early with data-driven drug target and biomarker qualification.

Related videos

Gene Variant Databases

Access to real-world data and 2 decades of expert curation

2,703 views October 01, 2021

Across oncology applications, from research to molecular testing and...

Gene Variant Databases

Identify meaningful mutations in somatic tumor testing

1,200 views February 14, 2022

From Information Overload to Actionable Insights Precision medicine is...

Gene Variant Databases

Precisely target the causes of malignancy on a molecular level

454 views March 28, 2022

Key to precision oncology is the development of expert databases that...

Gene Variant Databases

How to simplify somatic NGS analysis & reduce literature review time by 90% with HSMD

373 views March 29, 2023

Across clinical oncology applications, from molecular testing to cancer...